Objective: Bone metastasis is a clinically important outcome of prostate carcinoma (PC). We focused on the phenotypic and functional characterization of a particularly aggressive phenotype within the androgen-independent bone metastasis-derived PC3 cell line. These cells, originated from the spontaneous conversion of a CD44-negative subpopulation, stably express the CD44v8-10 isoform (CD44v8-10pos) and display stem cell-like features and a marked invasive phenotype in vitro that is lost upon CD44v8-10 silencing. Methods: Flow cytometry, enzyme-linked immunoassay, immunofluorescence, and Western blot were used for phenotypic and immunologic characterization. Real-time quantitative polymerase chain reaction and functional assays were used to ...
[[abstract]]Background/Aim: CD44 and CD133 have been implicated as biomarkers of cancer cells and th...
Background: Bone metastases represent a common and severe complication in breast cancer, and the inv...
Background: Bone forming metastases are a common and disabling consequence of prostate cancer (CaP)....
Objective: Bone metastasis is a clinically important outcome of prostate carcinoma (PC). We focused ...
In human prostate cancer (PCa), the neuroendocrine cells, expressing the prostate cancer stem cell (...
Bone is the preferred site of prostate cancer metastasis, contributing to the morbidity and mortalit...
International audienceΔNp63α is a critical mediator of epithelial development and stem cell function...
The expression of certain CD44 variants has been linked with metastasis and tumour progression. In p...
Cluster of differentiation (CD)44 has been implicated in cancer metastasis to bone. Clinical and exp...
Prostate cancer (CaP) is the second leading malignancy in older men in Western countries. The role o...
Background/Aims: Metastasis is the major cause of death in patients with osteosarcoma. There is an u...
Background:Up to 80% of patients dying from prostate carcinoma have developed bone metastases that a...
Osteosarcoma (OS) is the most frequent primary malignant bone cancer in children and adolescents wit...
Background: Novel therapies for men with castration-resistant prostate cancer (CRPC) are needed, par...
International audienceBackground: Up to 80% of patients dying from prostate carcinoma have developed...
[[abstract]]Background/Aim: CD44 and CD133 have been implicated as biomarkers of cancer cells and th...
Background: Bone metastases represent a common and severe complication in breast cancer, and the inv...
Background: Bone forming metastases are a common and disabling consequence of prostate cancer (CaP)....
Objective: Bone metastasis is a clinically important outcome of prostate carcinoma (PC). We focused ...
In human prostate cancer (PCa), the neuroendocrine cells, expressing the prostate cancer stem cell (...
Bone is the preferred site of prostate cancer metastasis, contributing to the morbidity and mortalit...
International audienceΔNp63α is a critical mediator of epithelial development and stem cell function...
The expression of certain CD44 variants has been linked with metastasis and tumour progression. In p...
Cluster of differentiation (CD)44 has been implicated in cancer metastasis to bone. Clinical and exp...
Prostate cancer (CaP) is the second leading malignancy in older men in Western countries. The role o...
Background/Aims: Metastasis is the major cause of death in patients with osteosarcoma. There is an u...
Background:Up to 80% of patients dying from prostate carcinoma have developed bone metastases that a...
Osteosarcoma (OS) is the most frequent primary malignant bone cancer in children and adolescents wit...
Background: Novel therapies for men with castration-resistant prostate cancer (CRPC) are needed, par...
International audienceBackground: Up to 80% of patients dying from prostate carcinoma have developed...
[[abstract]]Background/Aim: CD44 and CD133 have been implicated as biomarkers of cancer cells and th...
Background: Bone metastases represent a common and severe complication in breast cancer, and the inv...
Background: Bone forming metastases are a common and disabling consequence of prostate cancer (CaP)....